JG
CRNX

Jain Global’s Crinetics Pharmaceuticals CRNX Stock Holding History

Jain Global’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$660K Buy
+17,627
New +$655K ﹤0.01% 1119
2025
Q4 		– Sell
-5,929
Closed -$247K – 1269
2025
Q3 		$247K Buy
+5,929
New +$190K ﹤0.01% 853

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jain Global's CRNX Position: Q2 2026 in Review

Jain Global opened a new position in Crinetics Pharmaceuticals (CRNX) in Q2 2026: 17,627 shares worth $660K. The stake represents ﹤0.01% of the portfolio and ranks #1119 among its holdings. This is a return to the name: Jain Global previously reported a position in CRNX as recently as Q3 2025.

Jain Global first reported a position in CRNX in Q3 2025 and has held it in 2 quarters since. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Jain Global held 17,627 shares of Crinetics Pharmaceuticals worth $660K as of Q2 2026.
  • Crinetics Pharmaceuticals was a new Jain Global position in Q2 2026.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1119 holding.
  • Jain Global first reported a position in Crinetics Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.